Immunic (IMUX) Other Non-Current Liabilities (2013 - 2019)
Immunic's (IMUX) quarterly Other Non-Current Liabilities came in at $41000.0 in Q3 2019, little changed quarter-over-quarter from $41000.0 in Q2 2019.
Immunic (IMUX) Other Non-Current Liabilities (2013 - 2019) Analysis & Trends
Immunic has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $41000.0 for Q3 2019.
- Other Non-Current Liabilities for Q3 2019 came in at $41000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was $41000.0 (changed N/A YoY), and the FY2015 annual result was $101000.0, down 58.09% from the prior year.
- Other Non-Current Liabilities came in at $41000.0 for Q3 2019 at Immunic, roughly flat from $41000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $200000.0 in Q1 2015 to a low of $41000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 41,000.00 |
| Jun 30, 2019 | 41,000.00 |
| Dec 31, 2015 | 101,000.00 |
| Sep 30, 2015 | 146,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Mar 31, 2015 | 200,000.00 |
| Dec 31, 2014 | 241,000.00 |
| Sep 30, 2014 | 283,000.00 |
| Jun 30, 2014 | 292,000.00 |
| Mar 31, 2014 | 279,000.00 |
| Dec 31, 2013 | 321,000.00 |